Alteration of sleep quality by pain medication: An overview

Sleep and Pain

Volumn , Issue , 2015, Pages 372-390

  Cairns, Brian E ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SURREY MEMORIAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975244070     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (121)

1. Anis NA, Berry SC, Burton NR, et al. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983; 79:565-575.
2. Arankowsky-Sandoval G, Gold PE. Morphine-induced deficits in sleep patterns: attenuation by glucose. Neurobiol Learn Mem 1995; 64:133-138.
3. Argyropoulos SV, Wilson SJ. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry 2005; 17:237-245.
4. Arnold LM, Keck PE, Welge JA. Antidepressant treatment of fibromyalgia. Psychosomatics 2000; 41:104-113.
5. Attal N, Gaude V, Brasseur L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000; 54:564-574.
6. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002; 59(Suppl 2):S14-S17.
7. Baker FC, Driver HS, Paiker J, et al. Acetaminophen does not affect 24-h body temperature or sleep in the luteal phase of the menstrual cycle. J Appl Physiol 2002; 92:1684-1691.
8. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE (Eds). The Pharmacological Basis of Therapeutics, 10th ed. Toronto: McGraw-Hill, 2001, pp 447-483.
9. Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiatry 1974; 8:47-54.
10. Basheer R, Strecker RE, Thakkar MM, et al. Adenosine and sleep-wake regulation. Prog Neurobiol 2004; 73:379-396.
11. Bazil CW. Effects of antiepileptic drugs on sleep structure: are all drugs equal? CNS Drugs 2003; 17:719-728.
12. Cairns BE, McErlane SA, Fragoso MC, et al. Tooth pulp-and facial hair mechanoreceptor-evoked responses of trigeminal sensory neurons are attenuated during ketamine anesthesia. Anesthesiology 1999; 91:1025-1035.
13. Capece ML, Baghdoyan HA, Lydic R. Opioids activate G proteins in REM sleep-related brain stem nuclei of rat. Neuroreport 1998; 9:3025-3028.
14. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996; 52(Suppl 5):13-23.
15. Chalon S, Pereira A, Lainey E, et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology 2005; 177:357-365.
16. Collingridge GL, Lester RA. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 1989; 41:143-210.
17. Colombo B, Annovazzi POL, Comi G. Mechanisms and treatment of neuropathic pain. Neurol Sci 2006; 27:S183-S189.
18. Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol 2004; 61:149-160.
19. Cronin A, Keifer JC, Baghdoyan HA, et al. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 1995; 74:188-192.
20. Cronin AJ, Keifer JC, Davies MF, et al. Postoperative sleep disturbance: influences of opioids and pain in humans. Sleep 2001; 24:39-44.
21. Curran MP, Wagstaff AJ. Gabapentin in postherpetic neuralgia. CNS Drugs 2003; 17:975-982.
22. de Andres I, Villablanca JR, Burgess JW. Reassessing morphine effects in cats: II. Protracted effects on sleep-wakefulness and the EEG. Pharmacol Biochem Behav 1984; 21:923-928.
23. Echols SD, Jewett RE. Effects of morphine on sleep in the cat. Psychopharmacologia 1972; 24:435-448.
24. Eisenberg E, Shifrin A, Krivoy N. Lamotrigine for neuropathic pain. Expert Rev Neurother 2005; 5:729-735.
25. Espana RA, Scammell TE. Sleep neurobiology for the clinician. Sleep 2004; 27:811-820.
26. Fantini ML, Gagnon JF, Filipini D, et al. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003; 61:1418-1420.
27. Feinberg I, Campbell IG. Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology 1993; 9:41-48.
28. Feinberg I, Jones R, Walker J, et al. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther 1976; 19:782-794.
29. Finnimore AJ, Roebuck M, Sajkov D, et al. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995; 8:230-234.
30. Foldvary N, Perry M, Lee J, et al. The effects of lamotrigine on sleep in patients with epilepsy. Epilepsia 2001; 42:1569-1573.
31. Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 2002; 43:1493-1497.
32. Fowler CJ, Holt S, Nilsson O, et al. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacol Biochem Behav 2005; 81:248-262.
33. Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs 2005; 65:111-118.
34. Freemon FR. The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers. Drug Alcohol Depend 1982; 10:345-353.
35. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59:1573-1579.
36. Garzon M, Tejero S, Beneitez AM, et al. Opiate microinjections in the locus coeruleus area of the cat enhance slow wave sleep. Neuropeptides 1995; 29:229-239.
37. Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha 2 delta subunit of a calcium channel. J Biol Chem 1996; 271:5768-5776.
38. Gottesmann C. Brain inhibitory mechanisms involved in basic and higher integrated sleep processes. Brain Res Rev 2004; 45:230-249.
39. Gotzsche PC. Non-steroidal anti-inflammatory drugs. BMJ 2000; 320:1063-1070.
40. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE (Eds). The Pharmacological Basis of Therapeutics, 10th ed. Toronto: McGraw-Hill, 2001, pp 569-620.
41. Hayaishi O, Huang ZL. Role of orexin and prostaglandin E2 in activating histaminergic neurotransmission. Drug News Perspect 2004; 17:105-109.
42. Hayaishi O, Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2001; 8:12-15.
43. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005; 28:187-193.
44. Hobson JA, Datta S, Calvo JM, et al. Acetylcholine as a brain state modulator: triggering and long-term regulation of REM sleep. Prog Brain Res 1993:389-403.
45. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005; 52:2495-2505.
46. Horne JA, Percival JE, Traynor JR. Aspirin and human sleep. Electroencephalogr Clin Neurophysiol 1980; 49:409-413.
47. Huynh N, Lavigne GJ, Lanfranchi PA, et al. The effect of 2 sympatholytic medications-propranolol and clonidine-on sleep bruxism: experimental randomized controlled studies. Sleep 2006; 29:307-316.
48. Jacobs BL, Fornal CA. An integrative role for serotonin in the central nervous system. In: Lydic R, Baghdoyan HA (Eds). Handbook of Behavioral Sleep State Control: Cellular and Molecular Mechanisms. New York: CRC Press, 1998, pp 181-194.
49. Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 2002; 6(Suppl A):61-68.
50. Jonsson KO, Holt S, Fowler CJ. The endocannabinoid system: current pharmacological research and therapeutic possibilities. Basic Clin Pharmacol Toxicol 2006; 98:124-134.
51. Kay DC. Human sleep during chronic morphine intoxication. Psychopharmacologia 1975a; 44:117-124.
52. Kay DC. Human sleep and EEG through a cycle of methadone dependence. Electroencephalogr Clin Neurophysiol 1975b; 38:35-43.
53. Kay DC, Eisenstein RB, Jasinski DR. Morphine effects on human REM state, waking state and NREM sleep. Psychopharmacologia 1969; 14:404-416.
54. Kay DC, Pickworth WB, Neidert GL, et al. Opioid effects on computer-derived sleep and EEG parameters in nondependent human addicts. Sleep 1979; 2:175-191.
55. Kay DC, Pickworth WB, Neider GL. Morphine-like insomnia from heroin in nondependent human addicts. Br J Clin Pharmacol 1981; 11:159-169.
56. King C, Masserano JM, Codd E, et al. Effects of beta-endorphin and morphine on the sleep-wakefulness behavior of cats. Sleep 1981; 4:259-262.
57. Knill RL, Moote CA, Skinner MI, et al. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology 1990; 73:52-61.
58. Kundermann B, Krieg JC, Schreiber W, et al. The effect of sleep deprivation on pain. Pain Res Manag 2004; 9:25-32.
59. Lagos P, Scorza C, Monti JM, et al. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 1998; 8:113-120.
60. Landis CA, Robinson CR, Helms C, et al. Differential effects of acetylsalicylic acid and acetaminophen on sleep abnormalities in a rat chronic pain model. Brain Res 1989; 488:195-201.
61. Lanfumey L, Dugovic C, Adrien J. Beta 1 and beta 2 adrenergic receptors: their role in the regulation of paradoxical sleep in the rat. Electroencephalogr Clin Neurophysiol 1985; 60:558-567.
62. Lavie P, Hahir M, Lorder M, et al. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Lack of association between clinical improvement and effects on sleep. Arthritis Rheum 1991; 34:655-659.
63. Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med 2003; 4:51-55.
64. Lodge D, Johnson KM. Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 1990; 11:81-86.
65. Luppi P-H, Peyron C, Rampon C, et al. Inhibitory mechanisms in the dorsal raphe nucleus and locus coeruleus during sleep. In: Lydic R, Baghdoyan HA (Eds). Handbook of Behavioral State Control: Cellular and Molecular Mechanisms. New York: CRC Press, 1998, pp 195-212.
66. Lydic R, Baghdoyan HA. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep 2002; 25:617-622.
67. Lydic R, Keifer JC, Baghdoyan HA, et al. Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine. Anesthesiology 1993; 79:1003-1012.
68. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006; 46:101-122.
69. Makela JP, Hilakivi IT. Evidence for the involvement of alpha-2 adrenoceptors in the sedation but not REM sleep inhibition by clonidine in the rat. Med Biol 1986; 64:355-360.
70. May ME, Harvey MT, Valdovinos MG, et al. Nociceptor and age specific effects of REM sleep deprivation induced hyperalgesia. Behav Brain Res 2005; 159:89-94.
71. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol Clin Exp 2005; 20:533-559.
72. McNamara JO. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE (Eds). The Pharmacological Basis of Therapeutics, 10th ed. Toronto: McGraw-Hill, 2001, pp 521-547.
73. Mendelson WB, Gillin JC, Dawson SD, et al. Effects of melatonin and propranolol on sleep of the rat. Brain Res 1980; 201:240-244.
74. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 2002; 5(Suppl):1071-1075.
75. Moreton JE, Davis WM. Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat. Neuropharmacology 1973; 12:897-907.
76. Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, et al. Anandamide modulates sleep and memory in rats. Brain Res 1998; 812:270-274.
77. Murillo-Rodriguez E, Cabeza R, Mendez-Diaz M, et al. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 2001; 12:2131-2136.
78. Murphy PJ, Badia P, Myers BL, et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 1994; 55:1063-1066.
79. Naito K, Osama H, Ueno R, et al. Suppression of sleep by prostaglandin synthesis inhibitors in unrestrained rats. Brain Res 1988; 453:329-336.
80. Navarro L, Martinez-Vargas M, Murillo-Rodriguez E, et al. Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. Neuroscience 2003; 120:855-859.
81. Nelson LE, Guo TZ, Lu J, et al. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002; 5:979-984.
82. Nicholson AN, Turner C, Stone BM, et al. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004; 24:305-313.
83. Oga K, Kojima T, Matsuura M, et al. Effects of low-dose ketamine on neuropathic pain: an electroencephalogram-electrooculogram/behavioral study. Psychiatry Clin Neurosci 2002; 56:355-363.
84. Onen SH, Alloui A, Eschallier A, et al. Vocalization thresholds related to noxious paw pressure are decreased by paradoxical sleep deprivation and increased after sleep recovery in rat. Neurosci Lett 2000; 291:25-28.
85. Onen SH, Jourdan D, Eschallier A, et al. Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 2001a; 900:261-267.
86. Onen SH, Alloui A, Gross A, et al. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001b; 10:35-42.
87. Placidi F, Marciani MG, Diomedi M, et al. Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurol Scand 2000; 102:81-86.
88. Raymond I, Nielsen TA, Lavigne G, et al. Quality of sleep and its daily relationship to pain intensity in hospitalized adult burn patients. Pain Res Manag 2001; 92:381-388.
89. Raymond I, Ancoli-Israel S, Choiniere M. Sleep disturbances, pain and analgesia in adults hospitalized for burn injuries. Sleep Med 2004; 5:551-559.
90. Riemann D, Velthaus S, Laubenthal S, et al. REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials. Pharmacopsychiatry 1990; 23:253-258.
91. Robert C, Stinus L, Limoge A. Sleep impairments in rats implanted with morphine pellets. Neuropsychobiology 1999; 40:214-217.
92. Roehrs T, Hyde M, Blaisdell B, et al. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006; 29:145-151.
93. Ruigt GS, Kemp B, Groenhout CM, et al. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990; 38:551-554.
94. Saarto T, Wiffen P. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005; CD005454.
95. Saletu B, Frey R, Krupka M, et al. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 1991; 14:439-447.
96. Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 2002; 252:185-194.
97. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437:1257-1263.
98. Schachter SC. Tiagabine. Epilepsia 1999; 40(Suppl 5):S17-S22.
99. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002; 966:343-354.
100. Scheller M, Bufler J, Hertle I, et al. Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state. Anesth Analg 1996; 83:830-836.
101. Schutz TCB, Andersen ML, Tufik S. Sleep alterations in an experimental orofacial pain model in rats. Brain Res 2003; 993:164-171.
102. Seidel WF, Maze M, Dement WC, et al. Alpha-2 adrenergic modulation of sleep: time-of-daydependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat. J Pharmacol Exp Ther 1995; 275:263-273.
103. Sharpley AL, Williamson DJ, Attenburrow ME, et al. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology (Berl) 1996; 126:50-54.
104. Shaw IR, Lavigne G, Mayer P, et al. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 2005; 28:677-682.
105. Shen J, Kennedy SH, Levitan RD, et al. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. J Psychiatry Neurosci 2005; 30:11-16.
106. Siegel J. Brain mechanisms that control sleep and waking. Naturwissenschaften 2004; 91:355-365.
107. Soderpalm B. Anticonvulsants: aspects of their mechanism of action. Eur J Pain 2002; 6(Suppl A):3-9.
108. Staner L, Kerkhofs M, Detroux D, et al. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 1995; 18:470-477.
109. Stone WS, Walker DL, Gold PE. Sleep deficits in rats after NMDA receptor blockade. Physiol Behav 1992; 52:609-612.
110. Takahashi S, Kushikata T, Matsuki A. Effects of isoflurane and ketamine on sleep in rabbits. Psychiatry Clin Neurosci 2001; 55:239-240.
111. Todorov AA, Kolchev CB, Todorov AB. Tiagabine and gabapentin for the management of chronic pain. Clin J Pain 2005; 21:358-361.
112. Trampus M, Conti A, Marzanatti M, et al. Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat. Neuropharmacology 1990; 29:199-205.
113. Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion forrelief of ongoing neuropathic pain. Clin J Pain 2006; 22:266-271.
114. Ukponmwan OE, Rupreht J, Dzoljic MR. REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water-swim. Gen Pharmacol 1984; 15:255-258.
115. Wagner ML, Walters AS, Coleman RG, et al. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996; 19:52-58.
116. Walder B, Tramer MR, Blois R. The effects of two single doses of tramadol on sleep: a randomized, cross-over trial in healthy volunteers. Eur J Anaesthesiol 2001; 18:36-42.
117. Walker JS. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol 1995; 22:855-860.
118. Walsh JK, Randazzo AC, Frankowski S, et al. Dose-response effects of tiagabine on the sleep of older adults. Sleep 2005; 28:673-676.
119. Walsh JK, Zammit G, Schweitzer PK, et al. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia. Sleep Med 2006; 7:155-161.
120. Winokur A, DeMartinis NA III, McNally DP, et al. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003; 64:1224-1229.
121. Young GA, Khazan N. Comparison of abstinence syndromes following chronic administration of mu and kappa opioid agonists in the rat. Pharmacol Biochem Behav 1985; 23:457-460.